Matthew J. Romano, PA-C

Matthew Romano practices at Digestive Disease Center of CNY in Liverpool, New York.

Matthew Romano's NPI, 1073996567, was assigned on July 2, 2015. Matthew Romano holds New York license 018725.

Matthew Romano's primary practice is Digestive Disease Center of CNY, at 5112 West Taft Rd Suite E, Liverpool, NY 13088. The practice phone is (315) 449-2208.

Matthew Romano's primary practice is Digestive Disease Center of CNY in Liverpool, New York. Matthew Romano is also affiliated with Upstate University Hospital. The medical group on file is Gastroenterology & Hepatology of CNY. Dmand AI also links Matthew Romano to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Romano practices, 6 sites in all. Vendor and product names are available with a free account.

Physician assistant is Matthew Romano's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Matthew Romano is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Matthew Romano is licensed in New York.

Dmand AI lists vitamin d deficiency among the conditions Matthew Romano treats.

CMS data shows 18 Medicare services from Matthew Romano across 1 procedure code in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $745 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw Matthew Romano in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high cholesterol, and 58% have high blood pressure. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Matthew Romano's median patient age at 61, with 52% women.

In 2024, Matthew Romano wrote 5,640 Medicare Part D claims for 1,647 patients. 82% of them were for generic drugs. CMS names the drug for 5,495 of them, across 41 drugs with 11 or more claims each, at $791,482 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Matthew Romano for performance year 2024, reported as part of a group. Matthew Romano accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Matthew Romano from 5 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $62.